Literature DB >> 30779091

Bone marrow stem cells derived exosomes improve osteoporosis by promoting osteoblast proliferation and inhibiting cell apoptosis.

Y Xie1, J-H Hu, H Wu, Z-Z Huang, H-W Yan, Z-Y Shi.   

Abstract

OBJECTIVE: The aim of this study was to investigate whether bone marrow stem cells (MSCs) derived exosomes in rats could promote osteoblast proliferation and improve osteoporosis via inhibiting cell apoptosis.
MATERIALS AND METHODS: MSCs in rats were isolated and cultured, followed by the identification of surface antigens via flow cytometry. The differentiation of MSCs was detected by alizarin red staining and oil red staining. After extraction from MSCs by ultracentrifugation, the size distribution of exosomes was detected by tunable resistive pulse sensing (TRPS). Specific antigens in MSCs-derived exosomes were determined by flow cytometry. Furthermore, the proliferation and viability of hFOB1.19 cells treated with MSCs-derived exosomes were detected by cell count kit-8 (CCK-8) assay. The effect of MSCs-derived exosomes on cell apoptosis was evaluated by flow cytometry. Protein expression levels of apoptosis-related genes in hFOB1.19 cells were detected by Western blot.
RESULTS: MSCs differentiated into osteoblasts and lipoblasts under different treatments. Meanwhile, MSCs-derived exosomes exhibited typical elongated morphology after isolation and culture for 1 and 3 days, respectively. Functionally, MSCs-derived exosomes could promote the viability of hFOB1.19 cells, and significantly increase the expression level of GLUT3. In addition, MSCs-derived exosomes remarkably downregulated apoptosis-related genes and decreased apoptosis in hFOB1.19 cells.
CONCLUSIONS: MSCs-derived exosomes could promote osteoblast proliferation via inhibiting cell apoptosis, eventually improving osteoporosis.

Entities:  

Year:  2019        PMID: 30779091     DOI: 10.26355/eurrev_201902_17014

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  12 in total

Review 1.  Bone marrow mesenchymal stem cell's exosomes as key nanoparticles in osteogenesis and bone regeneration: specific capacity based on cell type.

Authors:  Mohammad Sadegh Gholami Farashah; Maryam Javadi; Amirhossein Mohammadi; Jafar Soleimani Rad; Seyed Kazem Shakouri; Leila Roshangar
Journal:  Mol Biol Rep       Date:  2022-10-12       Impact factor: 2.742

2.  CD146+Mesenchymal stem cells treatment improves vascularization, muscle contraction and VEGF expression, and reduces apoptosis in rat ischemic hind limb.

Authors:  Tao Chen; Bo Ye; Jing Tan; Haifeng Yang; Faming He; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2021-04-21       Impact factor: 6.100

3.  Exosomes derived from circRNA Rtn4-modified BMSCs attenuate TNF-α-induced cytotoxicity and apoptosis in murine MC3T3-E1 cells by sponging miR-146a.

Authors:  Guijun Cao; Xianqing Meng; Xiaodong Han; Jinhua Li
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

Review 4.  Promising diagnostic and therapeutic circRNAs for skeletal and chondral disorders.

Authors:  Gaoyang Chen; Wanze Tang; Shang Wang; Canling Long; Xiaoqin He; Dazhi Yang; Songlin Peng
Journal:  Int J Biol Sci       Date:  2021-04-07       Impact factor: 6.580

5.  Exosomes from tendon derived stem cells promote tendon repair through miR-144-3p-regulated tenocyte proliferation and migration.

Authors:  Kai Song; Tao Jiang; Pin Pan; Yao Yao; Qing Jiang
Journal:  Stem Cell Res Ther       Date:  2022-02-23       Impact factor: 6.832

6.  Proteomic Comparison of Bone Marrow Derived Osteoblasts and Mesenchymal Stem Cells.

Authors:  Elise Aasebø; Annette K Brenner; Maria Hernandez-Valladares; Even Birkeland; Frode S Berven; Frode Selheim; Øystein Bruserud
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

Review 7.  The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes for Orthopedic Diseases Treatment.

Authors:  Kosar Malekpour; Ali Hazrati; Marziah Zahar; Alexander Markov; Angelina Olegovna Zekiy; Jamshid Gholizadeh Navashenaq; Leila Roshangar; Majid Ahmadi
Journal:  Stem Cell Rev Rep       Date:  2021-06-24       Impact factor: 6.692

8.  Bone marrow mesenchymal stem cells-derived exosomal microRNA-193a reduces cisplatin resistance of non-small cell lung cancer cells via targeting LRRC1.

Authors:  Hongbo Wu; Xiaoqian Mu; Lei Liu; Huijuan Wu; Xiufeng Hu; Lijuan Chen; Jie Liu; Yu Mu; Fangfang Yuan; Wenjing Liu; Yanqiu Zhao
Journal:  Cell Death Dis       Date:  2020-09-25       Impact factor: 8.469

Review 9.  Preparing the Bone Tissue Regeneration Ground by Exosomes: From Diagnosis to Therapy.

Authors:  Batla Al-Sowayan; Farah Alammari; Alaa Alshareeda
Journal:  Molecules       Date:  2020-09-14       Impact factor: 4.411

Review 10.  Exosomes: A Friend or Foe for Osteoporotic Fracture?

Authors:  Zhimin Yang; Wenchao Zhang; Xiaolei Ren; Chao Tu; Zhihong Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-21       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.